Global Market for Wound Closure Products to Reach $4.6 Billion in
2016; European Market for Electrosurgical Devices to Reach $140
Million in Sales by 2016
FARMINGTON, Conn., Nov. 6, 2012 /PRNewswire-iReach/ -- Research
universities such as Columbia, New York
University, Northwestern and the
University of California system receive
hefty incomes through licensing royalties from medical devices or
technologies that were discovered and patented at their
institution. For example, Wake Forest University licensed patents
for a negative-pressure wound-therapy device to Kinetic Concepts
Inc. in 1993, which has brought in $500
million for the school since then.
(Photo: http://photos.prnewswire.com/prnh/20121106/CG07254)
For researchers, medical equipment companies, and investors who
want to learn more about what the current and future shape of the
market for wound closure technologies and biomaterials and
electrosurgical devices, Global Information Inc (GII) recommends
three noteworthy market research reports from our premium research
partners.
US Markets for Current and Emerging Wound Closure
Technologies
Nearly 100 million wounds were treated in U.S. hospitals in
2011. Treatment of these wounds generated over $3.8 billion in
wound closure product sales (including traditional products such as
sutures, stapling systems, and wound closure strips, as well as
emerging products such as surgical sealants and glues, energy-based
closure devices, automated suturing products, and negative pressure
wound therapy systems).
Medtech Insight's new report presents a detailed overview of the
U.S. current and emerging wound closure products market. Major
topics covered by this report include a an overview of the
physiology of wound closure; a discussion of traditional wound
closure products such as sutures, stapling products, and wound
closure strips; a discussion of emerging wound closure products
such as surgical sealants and glues, energy-based closure devices,
automated suturing devices, and negative pressure wound therapy
products; and analyses of the sales and leading competitors in each
of these markets.
An Executive Summary for this report and free sample pages from
the full document are available at
http://www.giiresearch.com/report/mh107961-wound-closure.html
European Electrosurgical Devices Market
In 2011, the total electrosurgical devices market in Europe was
valued at nearly $480 million. Over
the forecast period covered by this report, the value of this
market is projected to grow at a compound annual rate of greater
than 5.0%, increasing by more than $140.0
million in sales by the year 2016. While all segments are
projected to maintain stable and moderate growth, the largest
market segment - thermal ligature devices - is projected to
increase at the highest compound annual rate due to strong demand,
growing utilization, introduction of several new, next-generation
devices, and the clinical and cost efficacy of electrothermal
products.
This report provides insight and analysis for selected
traditional and specialized electrosurgical generator systems,
handheld instruments and accessories, thermal ligature systems and
next-generation electrosurgical products.
An Executive Summary for this report and free sample pages from
the full document are available at
http://www.giiresearch.com/report/mh253251-european-electrosurgical-devices-market.html
US Markets for Wound Care Biomaterials 2012
Driven by favorable demographic factors, as well as the
increasing demand for greater cost efficiencies, adoption of
premium-priced negative-pressure wound therapy (NPWT) systems will
overcome slower growth in the advanced wound dressing segment and
facilitate moderate revenue expansion in the overall US market for
wound care biomaterials through 2016.
Companies covered in this report include: 3M Health Care,
Albahealth, ATMOS, Bard Peripheral Vascular, BSN medical,
Coloplast, ConvaTec, Covidien, Cura Surgical, Derma Sciences,
DeRoyal, Ethicon, Ferris Manufacturing, Genadyne Biotechnologies,
Gentell, Healthpoint Biotherapeutics, HemCon Medical Technologies,
Hollister Wound Care, Human BioSciences, Innovative Therapies,
Integra LifeSciences, Kalypto Medical, Lohmann & Rauscher
International, McKesson, Medela, Medline Industries, Medtronic,
Molnlycke Health Care, Ohio Medical Corporation, PolyRemedy, Premco
Medical Systems, Prospera, SANUWAVE Health, Smith & Nephew, Spiracur, Systagenix, Talley
Group, UDL Laboratories, and Vomaris Innovations.
An Executive Summary for this report and free sample pages from
the full document are available at
http://www.giiresearch.com/report/mrg251875-us-markets-wound-care-biomaterials.html
About Global Information Inc. Global Information (GII)
(http://www.giiresearch.com) is an information service company
partnering with over 300 research companies around the world.
Global Information has been in the business of distributing
technical and market research for more than 25 years. Expanded from
its original headquarters in Japan, Global Information now has offices in
Korea, Taiwan, Singapore, Europe and the
United States.
Media Contact: Jeremy Palaia Global Information, Inc.,
1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Global Information Inc.